Development and characterization of phospholipid-stabilized submicron aqueous dispersions of coenzyme Q₁₀ presenting continuous vibrating-mesh nebulization performance

References

• Abdelrahim ME, Plant P, Chrystyn H. (2010). In-vitro characterisation of the nebulised dose during non-invasive ventilation. J Pharm Pharmacol 62:966–72
   PubMed Web of Science ®Google Scholar
• Alfridsson M, Ninham B, Wall S. (2000). Role of Co-Ion specificity and dissolved atmospheric gas in colloid interaction. Langmuir 16:10087–91
   Web of Science ®Google Scholar
• Barnes HA, Hutton JF, Walters K. (1989). Rheology of suspensions. In: Walters K, ed. An introduction to rheology. Amsterdam, The Netherlands: Elsevier, 115--37
   Google Scholar
• Bhagavan HN, Chopra RK. (2006). Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics. Free Rad Res 40:445–53
   PubMed Web of Science ®Google Scholar
• Bhagavan HN, Chopra RK. (2007). Plasma coenzyme Q10 response to oral ingestion of coenzyme Q10 formulations. Mitochondrion 7:S78–88
   PubMed Web of Science ®Google Scholar
• Bittar EE, ed. (2002). Alveolar surfactant. In: Pulmonary biology in health and disease. New York, NY, USA: Springer, 44--63
   Google Scholar
• Boe J, Dennis JH, O'Driscoll BR. (2001). European Respiratory Society Guidelines on the use of nebulizers. Eur Respirat J 18:228–42
   PubMed Web of Science ®Google Scholar
• Brea-Calvo G, Rodríguez-Hernández Á, Fernández-Ayala DJM, et al. (2006). Chemotherapy induces an increase in coenzyme Q10 levels in cancer cell lines. Free Rad Biol Med 40:1293–302
   PubMed Web of Science ®Google Scholar
• Carvalho T, Horng M, McConville J. (2012). Application of a pull on a disk method to measure surface tension of liquids. AAPS PharmSciTech 13:305–12
   PubMed Web of Science ®Google Scholar
• Carvalho TC, Peters JI, Williams III RO. (2011). Influence of particle size on regional lung deposition – What evidence is there? Int J Pharma 406:1–10
   PubMed Web of Science ®Google Scholar
• Dhanasekaran M, Ren J. (2005). The emerging role of coenzyme Q-10 in aging, neurodegeneration, cardiovascular disease, cancer and diabetes mellitus. Curr Neurovascular Res 2:447–59
   PubMed Web of Science ®Google Scholar
• Elhissi A, Gill H, Ahmed W, Taylor K. (2011). Vibrating-mesh nebulization of liposomes generated using an ethanol-based proliposome technology. J Liposome Res 21:173–80
   PubMed Web of Science ®Google Scholar
• Elhissi AMA, Faizi M, Naji WF, et al. (2007). Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures. Int J Pharma 334:62–70
   PubMed Web of Science ®Google Scholar
• Elhissi AMA, Karnam KK, Danesh-Azari MR, et al. (2006). Formulations generated from ethanol-based proliposomes for delivery via medical nebulizers. J Pharm Pharmacol 58:887–94
   PubMed Web of Science ®Google Scholar
• Elhissi AMA, Taylor KMG. (2005). Delivery of liposomes generated from proliposomes using air-jet, ultrasonic, and vibrating-mesh nebulisers. J Drug Deliv Sci Technol 15:261–5
   Web of Science ®Google Scholar
• Finer NN, Merritt TA, Bernstein G, et al. (2010). An open label, pilot study of Aerosurf® combined with nCPAP to prevent RDS in preterm neonates. J Aerosol Med Pulmonary Drug Deliv 23:303–9
   PubMed Web of Science ®Google Scholar
• Folkers K, Brown R, Judy WV, Morita M. (1993a). Survival of cancer patients on therapy with coenzyme Q10. Biochem Biophys Res Commun 192:241–5
   PubMed Web of Science ®Google Scholar
• Folkers K, Morita M, McRee J. (1993b). The activities of coenzyme-Q(10) and vitamin-B(6) for immune-responses. Biochem Biophys Res Commun 193:88–92
   PubMed Web of Science ®Google Scholar
• Ghazanfari T, Elhissi AMA, Ding Z, Taylor KMG. (2007). The influence of fluid physicochemical properties on vibrating-mesh nebulization. Int J Pharmaceut 339:103–11
   PubMed Web of Science ®Google Scholar
• Ghodrat M. (2006). Lung surfactants. Am J Health-System Pharm 63:1504–21
   PubMed Web of Science ®Google Scholar
• Gurkan AS, Bozdag-Dundar O. (2005). Coenzyme Q10. J Fac Pharm Ankara 34:129–54
   Google Scholar
• Hertz N, Lister RE. (2009). Improved survival in patients with end-stage cancer treated with coenzyme Q(10) and other antioxidants: a pilot study. J Int Med Res 37:1961–71
   PubMed Web of Science ®Google Scholar
• Hintze J. (2001). NCSS and PASS, released January 29th, 2004 edn. Kaysville, UT, USA: Number Cruncher Statistical Systems
   Google Scholar
• Jin YL, Chen JY, Xu L, Wang PN. (2006). Refractive index measurement for biomaterial samples by total internal reflection. Phys Med Biol 51:N371–9
   PubMed Web of Science ®Google Scholar
• Kawaguchi E, Shimokawa K, Ishii F. (2008). Physicochemical properties of structured phosphatidylcholine in drug carrier lipid emulsions for drug delivery systems. Colloids Surf B-Biointerfaces 62:130–5
   PubMed Web of Science ®Google Scholar
• Lasch J, Weissig V, Brandl M. (2003). Preparation of liposomes. In: Torchilin VP, Weissig V, eds. Liposomes: a practical approach. 2nd edn. Oxford, UK: Oxford University Press, 3--29
   Google Scholar
• Marple VA, Olson BA, Santhanakrishnan K, et al. (2004). Next generation pharmaceutical impactor: a new impactor for pharmaceutical inhaler testing. Part III. Extension of archival calibration to 15 L/min. J Aerosol Med-Depos Clear Eff Lung 17:335–43
   PubMedGoogle Scholar
• McConville JT, Overhoff KA, Sinswat P, et al. (2006). Targeted high lung concentrations of itraconazole using nebulized dispersions in a murine model. Pharmaceut Res 23:901–11
   PubMed Web of Science ®Google Scholar
• Mitchell JP, Nagel MW, Nichols S, Nerbrink O. (2006). Laser diffractometry as a technique for the rapid assessment of aerosol particle size from inhalers. J Aerosol Med-Depos Clear Eff Lung 19:409–33
   PubMedGoogle Scholar
• Narain NR, Li J, Russell KJ, et al. (2004a). Coenzyme Q10 inhibits the proliferation of oncogenic cells while stabilizing growth in primary cells in vitro. J Investigative Dermatol 122:167
   PubMed Web of Science ®Google Scholar
• Narain NR, Li J, Woan KV, et al. (2004b). Coenzyme Q10 induces apoptosis in human melanoma cells. J Investigative Dermatol 122:958
   Web of Science ®Google Scholar
• Ondarroa M, Sharma SK, Quinn PJ. (1986). Solvation properties of ubiquinone-10 in solvents of different polarity. Biosci Rep 6:783–96
   PubMed Web of Science ®Google Scholar
• Packhaeuser CB, Lahnstein K, Sitterberg J, et al. (2009). Stabilization of aerosolizable nano-carriers by freeze-drying. Pharmaceutical Res 26:129–38
   PubMed Web of Science ®Google Scholar
• Pilcer G, Amighi K. (2010). Formulation strategy and use of excipients in pulmonary drug delivery. Int J Pharmaceutics 392:1–19
   PubMed Web of Science ®Google Scholar
• Pinto L, Sloan A, Persaud I, Narain NR. (2009). Normalization of BCL-2 family members in breast cancer by coenzyme Q10. Ethnicity Dis 19:S17–18
   Web of Science ®Google Scholar
• Randall C. (1995). Particle size distribution. In: Brittain HG, ed. Physical characterization of pharmaceutical solids. New York, NY: M. Dekker, 157--86
   Google Scholar
• Rottier BL, van Erp CJP, Sluyter TS, et al. (2009). Changes in performance of the Pari eFlow® rapid and Pari LC Plus™ during 6 months use by CF patients. J Aerosol Med Pulm Drug Deliv 22:263–9
   PubMed Web of Science ®Google Scholar
• Rusciani L, Proietti I, Rusciani A, et al. (2006). Low plasma coenzyme Q10 levels as an independent prognostic factor for melanoma progression. J Am Acad Dermatol 54:234–41
   PubMed Web of Science ®Google Scholar
• Shekunov BY, Chattopadhyay P, Tong HHY, Chow AHL. (2007). Particle size analysis in pharmaceutics: principles, methods and applications. Pharmaceut Res 24:203–27
   PubMed Web of Science ®Google Scholar
• Siekmann B, Westesen K. (1995). Preparation and physicochemical characterization of aqueous dispersions of coenzyme Q10 nanoparticles. Pharmaceut Res 12:201–8
   PubMed Web of Science ®Google Scholar
• Smart J, Berg E, Nerbrink O, et al. (2002). TouchSpray™ technology: comparison of the droplet size measured with cascade impaction and laser diffraction. In: Dalby RN, Byron PR, Peart J, Farr SJ, eds. Respiratory drug delivery VIII, Tucson, AZ, USA. Richmond, VA, USA: Virginia Commonwealth University, 525–8
   Google Scholar
• Taeusch HW, Lu K, Ramierez-Schrempp D. (2002). Improving pulmonary surfactants. Acta Pharmacol Sinica 23:11–15
   Web of Science ®Google Scholar
• Tam JM, McConville JT, Williams RO, Johnston KP. (2008). Amorphous cyclosporin nanodispersions for enhanced pulmonary deposition and dissolution. J Pharmaceut Sci 97:4915–33
   PubMed Web of Science ®Google Scholar
• USP. (2011). <1601> Products for nebulization – characterization tests. In: The United States Pharmacopeial Convention, ed. USP 34-NF 29. Baltimore: United Book Press, Inc
   Google Scholar
• Vaughn JM, McConville JT, Burgess D, et al. (2006). Single dose and multiple dose studies of itraconazole nanoparticles. Eur J Pharmaceut Biopharmaceut 63:95–102
   PubMed Web of Science ®Google Scholar
• Washington C. (1996). Stability of lipid emulsions for drug delivery. Advanced Drug Deliv Rev 20:131–45
   Web of Science ®Google Scholar
• Watts AB, McConville JT, Williams RO. (2008). Current therapies and technological advances in aqueous aerosol drug delivery. Drug Develop Industrial Pharmacy 34:913–22
   PubMed Web of Science ®Google Scholar
• Wu YZ, Wang T. (2003a). Phospholipid class and FA compositions of modified soybeans processed with two extraction methods. J Am Oil Chemists Soc 80:127–32
   Web of Science ®Google Scholar
• Wu YZ, Wang T. (2003b). Soybean lecithin fractionation and functionality. J Am Oil Chemists Soc 80:319–26
   Web of Science ®Google Scholar
• Zhang G, David A, Wiedmann TS. (2007). Performance of the vibrating membrane aerosol generation device: aeroneb micropump nebulizer™. J Aerosol Med-Depos Clear Eff Lung 20:408–16
   PubMedGoogle Scholar